Sign in
Not yet taking people in United StatesNo phase

How growth hormone affects insulin-making cells in people with prediabetes

Studies how pancreas cells respond to growth hormone in adults with prediabetes.

Key facts

Who runs it
University of Missouri-Columbia
Where
Columbia, United StatesSee the site
Trial code
Registry title
Growth Hormone Resistance of Beta-cells
Status
Not yet recruiting
People taking part
10 people, planned
Started
1 Aug 2026
Expected to end
1 Sept 2030
Type of study
Observational, 2 groups
Record updated
6 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with impaired fasting glucose or impaired glucose tolerance (higher than normal blood sugar). It studies how growth hormone affects insulin-making cells.

Age
18 Years to 59 Years
Sex
All sexes
Disease stage
Impaired fasting glucose (100 to 126 mg/dL (5.6–7 mmol/L)) or impaired glucose tolerance (blood glucose 140 to 199 mg/dL (7.8–11 mmol/L) two hours after a 75g oral glucose tolerance test). Body mass index above 18.5 and below 45.9 kg/m2.
Earlier treatment
Cannot have had bariatric surgery or used medications that can affect the study results, such as GLP-1 receptor agonists.
Biomarker or test result
Fasting blood glucose of 100 to 126 mg/dL (5.6–7 mmol/L), or a blood glucose of 140 to 199 mg/dL (7.8–11 mmol/L) two hours after a 75g oral glucose tolerance test.

Main reasons for not taking part

  • Pregnant, planning pregnancy during the study, or breastfeeding
  • Current or past type 1 or type 2 diabetes
  • Bariatric surgery in the past
  • Current cancer, or cancer in remission less than 5 years
  • First degree relative with type 1 diabetes

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • body mass index >18.5kg/m2 and <45.9kg/m2
  • impaired fasting glucose >/= 100mg/dL, </= 126mg/dL or impaired glucose tolerance on 75g oral glucose tolerance test (blood glucose 140 to 199mg/dL at two-hours)

Who cannot take part

  • use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
  • current diagnosis or history of type 1 or type 2 diabetes
  • history of bariatric surgery
  • history of intracranial hypertension, including papilledema, or a condition that increases the risk of developing intracranial hypertension, such as Turner Syndrome, Prader-Willi Syndrome, or renal impairment
  • current cancer or cancer that has been in remission less than 5 years
  • first degree relative with type 1 diabetes
  • evidence of anemia or significant end organ dysfunction (e.g., liver, kidney, heart disease)
  • alcohol use disorder, use of controlled substances, or smoking >2 cigarettes per day
  • pregnant, planning to become pregnant during the study, or breastfeeding
  • known, uncontrolled hypothyroidism
  • greater than 3% weight loss within three months of screening or engaged in regular (>/= 3 days per week), continuous moderate- or high-intensity exercise of >/= 30 min duration
  • mentally disabled persons, prisoners, and persons with inability to grant voluntary informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 59 years old?

Where in United States

  • University of Missouri School of MedicineColumbia, United StatesContact: Study coordinatorNot yet recruiting

About the trial

What the trial wants to find out

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.

The 2 groups in the trial

  • Impaired fasting glucose
  • Impaired glucose tolerance

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Growth Hormone Resistance of Beta-cells in People With Impaired Fasting Glucose vs Impaired Glucose Tolerance
Plain-language title
How growth hormone affects insulin-making cells in people with prediabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07581860, who can take part
Record updated
6 August 2026